临床试验/CTRI/2025/02/080551

CTRI/2025/02/080551尚未招募不适用

Awareness and risk factors of Non Alcoholic Fatty Liver Disease (NAFLD) among patients of selected tertiary care hospital of Udupi district, Karnataka: A case –control study

Rachel R1 个研究点分布在 1 个国家目标入组 345 人开始时间: 2026年2月11日最近更新: 2025年1月31日

试验速览

阶段: 不适用
状态: 尚未招募
发起方
入组人数: 345
试验地点: 1
主要终点: At the end of the study the outcome measures are the awareness and the

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The data collection for the study will be done only after the approval from CTRI. The tentative data collection for the study is targeted from 2nd February 2025 to 9th March 2025 in the spend of one month. The participant will be recruited only after participant consenting the consent form.

研究设计

研究类型: Observational

入排标准

年龄范围: 19.00 Year(s) 至 80.00 Year(s)（—）
性别: All

入选标准

•Diagnosed patients with non-alcoholic fatty liver using ultrasonography.
•The patient’s age above 18 years Controls
•Patients without non-alcoholic fatty liver in the ultrasonography.
•The patient’s age above 18 years.

排除标准

•The patients with alcoholic fatty liver.
•The children below 18 years of age.
•The patients’ diagnosis with hepatitis B and hepatitis C infections.
•The patients diagnosed with fatty liver disease
•The patients with any other liver related issues.
•The patients with age below 18 years.

结局指标

主要结局

At the end of the study the outcome measures are the awareness and the

时间窗: 4 weeks

risk factors of Non alcoholic fatty liver disease (NAFLD) among patients of tertiary care hospital.

时间窗: 4 weeks

次要结局

NA(NA)

研究者

发起方

Rachel R

申办方类型

Other [self]

责任方

Principal Investigator

主要研究者

RACHEL R

Manipal college of Nursing, Manipal Academy of Higher Education

研究点 (1)

Loading locations...

相似试验

已完成

不适用

Prevalence and risk factors of non-alcoholic fatty liver disease (NAFLD) in polycystic ovary syndrome: a cross-sectional study

JPRN-UMIN000032783ational Hospital Organization Kyoto Medical Center200

尚未招募

不适用

Evaluation of the prevalence of non-alcoholic fatty liver disease (and steatohepatitis) in patients with type 2 diabetes mellitus100126531001796910013317NASHfatty liver

NL-OMON29718Vrije Universiteit Medisch Centrum1,500

尚未招募

2/3 期

Clinical features of fatty liver in non alcoholic and its association with obesity, type 2 diabetes

CTRI/2022/07/044146DR Basavesh Gongadashetti30

尚未招募

2 期

To compare Yakritshul Vinasini Vatika and Arogyavardhini Vati in the management of Non-Alcoholic Fatty Liver Disease (NAFLD)

CTRI/2025/11/097047Institute For Ayurved Studies And Research, Umri road, sector 8, Kurukshetra66

已完成

1 期

A study in people with overweight or obesity to test how BI 1820237, BI 456906, or a combination of both affects brain activityObesity

2023-506233-30-01Boehringer Ingelheim International GmbH24